Lumenis is the global leader in medical and aesthetic lasers and light-based technology, dedicated to improving people’s lives with advance technological solutions for treating their medical and cosmetic conditions.  Lighting the way to future life-enhancing technologies has been a guiding principle at Lumenis since 1966.  In following this principle we focus the resources of a truly global organisation on improving the lives of people and their clinicians.  The results are ground-breaking innovations, supported by thorough clinical evidence covering the entire spectrum of patient medical care, industry-leading support and service, as well as the finest training and education for our customers.

Lumenis® Introduces A New Multi-Application Platform:

The M22™ for Photorejuvenation, Permanent Hair Reduction, Age Spot Reduction And Vein Erasure

The new M22™ multi-application platform, features Lumenis’ proprietary Optimal Pulse Technology (OPT™) and Multiple-Sequential Pulsing

“M22™, a new modular, multi-application platform, featuring IPL and Nd:YAG, is the smart, simple and innovative choice from Lumenis,” says Mr. Robert Mann, SVP & General Manager of Lumenis’ Aesthetic Business. “It delivers everything that aesthetic practitioners need to enhance usability, including plug-and-play upgradability and a resourceful modular design for maximum versatility and the greatest return on investment.”

“As the inventor of IPL®, our new compact solution for light-based skin treatments continues our mission of creating world-class technology that ultimately helps our Customers grow profitable practices,” said Mr. Dov Ofer, Lumenis’ Chief Executive. “Scalable and designed to empower practitioners and their staff to consistently produce superior results, the M22™ delivers predictable treatment outcomes for over 30 applications,” Mr. Ofer continued.

About The M22™

The M22™ has the broadest range of energy for its size and application.  The streamlined tabletop modular platform comes out of the box ready for treatment.  Easy to install, and thanks to multi-lingual capability, user-friendly touch screen interface, and hundreds of pre-sets, the M22™ is simple, savvy and accessible.

“The M22™ delivers everything you’d expect from a multi-application platform, but takes its performance to the next level with accuracy, simplicity and expediency,” says Dr. Matthew Knight, FAAD, Knight Dermatology Institute in Orlando, FL. “And it’s set up for expansion, allowing for the treatment of multiple skin conditions with one device.”  OPT, unique to Lumenis IPL®, delivers the right pulse and fluence for each application.  Practitioners can safely and efficiently treat a variety of skin types by controlling each pulse shape. Multiple-Sequential Pulsing enables permanent hair reduction on darker skin as well as reducing the chance of skin damage in vascular and pigmented lesion treatment.

“Lumenis listened to what doctors, like myself, were asking for in a multi-application system,” says Dr. Guevara, DO, Ferrara Dermatology Clinic in Grosse Point, MI. “As the best option in this price range and the fastest table-top system on the market, the M22™ caters to our diverse needs, empowering us to deliver consistent results and keep our patients satisfied,” says Guevara.

Module Upgrade

The M22™ offers the Nd:YAG upgrade module, proven for vascular lesions, leg veins, and non-ablative facial wrinkle treatment. The treatment head is equipped with two spot sizes (2 x 4 mm and 6 mm) for precision treatment, complete with computer-enabled recognition and SapphireCool Light Guides for optimal patient comfort.  With more speed, power and mobility, Lumenis designed the M22™ to be all that physicians need in one attractively priced, multi-application platform. To learn more about the M22™, visit www.aesthetic.lumenis.com.

About Lumenis

Lumenis, a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic and ophthalmic applications, is Israel’s largest medical device company with more than 800 employees worldwide. With over 250 patents worldwide, over 75 FDA clearances, presence in over 100 countries worldwide, and an installed base of over 70,000

systems Lumenis invests heavily in R&D and holds a leading position in the markets it serves. For more information about Lumenis and its products, visit www.lumenis.com.

For further information in the UK contact:

E:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it